Anela joined Apollo Health Ventures as COO in 2020 and has since been helping shape R&D strategy and clinical development plans in the fund’s venture creations. She takes an active role and supports companies both as an advisor and operator as needed. She currently serves on the board of directors of several companies including Samsara Therapeutics, Cleara, Booster Therapeutics and RefoxyPharmaceuticals. In addition, Anela helps evaluate new investment opportunities and initiates company creation projects, especially in the area of neurodegeneratio n and brain health. Before joining Apollo Health Ventures, she worked at a boutique consulting firm Catenion T here she has managed international projects for Big Pharma and biotech upstarts regarding R&D strategy and advised top tier VC’s and hedge funds o n their investment decisions. Anela holds a PhD in neurobiology from the Free University of Berlin and her work was published in top ranked peer reviewed journals.
December 3rd & 4th, 2024
December 11th& 12th 2024